United States of America

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National

Download

Value (%)	Year	Type	Source
0.34 (0.30 - 0.38)	2019	Modelled	IHME
0.34 (0.30 - 0.38)	2018	Modelled	IHME
0.34 (0.30 - 0.39)	2017	Modelled	IHME
0.35 (0.31 - 0.39)	2016	Modelled	IHME
0.36 (0.32 - 0.41)	2015	Modelled	IHME
0.37 (0.33 - 0.42)	2014	Modelled	IHME
0.38 (0.33 - 0.42)	2013	Modelled	IHME
0.38 (0.34 - 0.43)	2012	Modelled	IHME
0.39 (0.34 - 0.44)	2011	Modelled	IHME
0.4 (0.35 - 0.45)	2010	Modelled	IHME
0.41 (0.36 - 0.46)	2009	Modelled	IHME
0.42 (0.37 - 0.47)	2008	Modelled	IHME
0.43 (0.37 - 0.48)	2007	Modelled	IHME
0.44 (0.38 - 0.49)	2006	Modelled	IHME
0.44 (0.39 - 0.50)	2005	Modelled	IHME
0.45 (0.39 - 0.51)	2004	Modelled	IHME
0.45 (0.40 - 0.51)	2003	Modelled	IHME
0.46 (0.40 - 0.52)	2002	Modelled	IHME
0.46 (0.40 - 0.52)	2001	Modelled	IHME
0.47 (0.41 - 0.52)	2000	Modelled	IHME
0.47 (0.41 - 0.53)	1999	Modelled	IHME
0.48 (0.42 - 0.54)	1998	Modelled	IHME
0.49 (0.42 - 0.55)	1997	Modelled	IHME
0.49 (0.43 - 0.56)	1996	Modelled	IHME
0.5 (0.43 - 0.56)	1995	Modelled	IHME
0.5 (0.44 - 0.57)	1994	Modelled	IHME
0.51 (0.44 - 0.58)	1993	Modelled	IHME
0.51 (0.45 - 0.58)	1992	Modelled	IHME
0.52 (0.45 - 0.59)	1991	Modelled	IHME
0.52 (0.45 - 0.59)	1990	Modelled	IHME
0.38 (0.29 - 0.49)	1994	Survey/reported	Wasley A et al, 2010
0.27 (0.20 - 0.35)	2006	Survey/reported	Wasley A et al, 2010
0.3 (0.20 - 0.40)	2012	Survey/reported	Roberts H et al, 2016
0.23 (0.18 - 0.28)	2015	Modelled	WHO
0.3 (0.20 - 0.30)	2016	Modelled	Razavi-Shearer et al, 2018
0.27 (0.24 - 0.30)	2013	Modelled	Schweitzer et al, 2015

Showing out of

Children under-5 years

Download

Value (%)	Year	Type	Source
0.03 (0.02 - 0.04)	2019	Modelled	IHME
0.03 (0.02 - 0.04)	2018	Modelled	IHME
0.03 (0.02 - 0.04)	2017	Modelled	IHME
0.03 (0.02 - 0.04)	2016	Modelled	IHME
0.03 (0.02 - 0.04)	2015	Modelled	IHME
0.03 (0.02 - 0.04)	2014	Modelled	IHME
0.03 (0.03 - 0.04)	2013	Modelled	IHME
0.03 (0.03 - 0.04)	2012	Modelled	IHME
0.04 (0.03 - 0.04)	2011	Modelled	IHME
0.04 (0.03 - 0.04)	2010	Modelled	IHME
0.03 (0.03 - 0.04)	2009	Modelled	IHME
0.03 (0.03 - 0.04)	2008	Modelled	IHME
0.03 (0.02 - 0.04)	2007	Modelled	IHME
0.03 (0.02 - 0.04)	2006	Modelled	IHME
0.03 (0.02 - 0.04)	2005	Modelled	IHME
0.03 (0.02 - 0.04)	2004	Modelled	IHME
0.03 (0.02 - 0.04)	2003	Modelled	IHME
0.03 (0.03 - 0.04)	2002	Modelled	IHME
0.04 (0.03 - 0.05)	2001	Modelled	IHME
0.04 (0.03 - 0.05)	2000	Modelled	IHME
0.04 (0.03 - 0.05)	1999	Modelled	IHME
0.04 (0.03 - 0.05)	1998	Modelled	IHME
0.04 (0.03 - 0.06)	1997	Modelled	IHME
0.05 (0.04 - 0.06)	1996	Modelled	IHME
0.05 (0.04 - 0.07)	1995	Modelled	IHME
0.06 (0.04 - 0.08)	1994	Modelled	IHME
0.07 (0.05 - 0.09)	1993	Modelled	IHME
0.09 (0.07 - 0.11)	1992	Modelled	IHME
0.11 (0.08 - 0.13)	1991	Modelled	IHME
0.13 (0.10 - 0.16)	1990	Modelled	IHME
0.04 (0.03 - 0.05)	2015	Modelled	WHO

Showing out of

Technical notes

Number of people living with chronic HBV

National

Download

Value	Year	Type	Source
1,317,810 (1,141,740 - 1,502,300)	1990	Modelled	IHME
1,324,240 (1,147,580 - 1,507,310)	1991	Modelled	IHME
1,329,060 (1,153,480 - 1,508,030)	1992	Modelled	IHME
1,332,170 (1,156,540 - 1,512,760)	1993	Modelled	IHME
1,333,670 (1,159,600 - 1,507,970)	1994	Modelled	IHME
1,333,900 (1,159,670 - 1,504,050)	1995	Modelled	IHME
1,331,460 (1,158,810 - 1,498,340)	1996	Modelled	IHME
1,326,130 (1,153,930 - 1,494,180)	1997	Modelled	IHME
1,319,570 (1,149,530 - 1,484,540)	1998	Modelled	IHME
1,313,590 (1,146,460 - 1,476,340)	1999	Modelled	IHME
1,310,100 (1,142,500 - 1,472,620)	2000	Modelled	IHME
1,309,770 (1,143,240 - 1,473,390)	2001	Modelled	IHME
1,311,250 (1,143,560 - 1,474,490)	2002	Modelled	IHME
1,313,140 (1,147,220 - 1,476,360)	2003	Modelled	IHME
1,313,740 (1,147,160 - 1,476,070)	2004	Modelled	IHME
1,311,240 (1,142,650 - 1,473,160)	2005	Modelled	IHME
1,302,020 (1,136,430 - 1,465,600)	2006	Modelled	IHME
1,285,820 (1,126,040 - 1,446,130)	2007	Modelled	IHME
1,265,750 (1,112,440 - 1,424,060)	2008	Modelled	IHME
1,245,300 (1,096,350 - 1,399,520)	2009	Modelled	IHME
1,228,380 (1,079,050 - 1,381,060)	2010	Modelled	IHME
1,216,570 (1,069,660 - 1,365,180)	2011	Modelled	IHME
1,207,220 (1,061,900 - 1,352,310)	2012	Modelled	IHME
1,197,990 (1,053,860 - 1,340,010)	2013	Modelled	IHME
1,186,460 (1,041,800 - 1,328,430)	2014	Modelled	IHME
1,169,910 (1,025,460 - 1,309,720)	2015	Modelled	IHME
1,136,010 (994,511 - 1,273,420)	2016	Modelled	IHME
1,109,810 (970,219 - 1,253,650)	2017	Modelled	IHME
1,106,910 (968,416 - 1,250,170)	2018	Modelled	IHME
1,108,930 (968,729 - 1,253,410)	2019	Modelled	IHME
875,000 (654,000 - 1,033,000)	2016	Modelled	Razavi-Shearer et al, 2018
862,000	2016	Survey/reported	Patel EU, Thio CL, Boon D, Thomas DL, Tobian AAR
2,400,000	2016	Survey/reported	Wong, R.J. et al

Showing out of

Number of new cases of HBV

National

Download

Value	Year	Type	Source
20,700 (11,800 - 50,800)	2019	Survey/reported	US CDC: Viral Hepatitis Surveillance Report 2019 - Hepatitis B

HBV-related death rate

National

Download

Value (per 100,000)	Year	Type	Source
1.37 (1.18 - 1.58)	2019	Modelled	IHME
1.36 (1.18 - 1.55)	2018	Modelled	IHME
1.34 (1.17 - 1.52)	2017	Modelled	IHME
1.4 (1.25 - 1.57)	2016	Modelled	IHME
1.43 (1.28 - 1.59)	2015	Modelled	IHME
1.39 (1.25 - 1.54)	2014	Modelled	IHME
1.35 (1.22 - 1.50)	2013	Modelled	IHME
1.31 (1.18 - 1.45)	2012	Modelled	IHME
1.27 (1.15 - 1.40)	2011	Modelled	IHME
1.24 (1.12 - 1.36)	2010	Modelled	IHME
1.22 (1.11 - 1.34)	2009	Modelled	IHME
1.2 (1.10 - 1.32)	2008	Modelled	IHME
1.19 (1.08 - 1.29)	2007	Modelled	IHME
1.18 (1.08 - 1.28)	2006	Modelled	IHME
1.16 (1.06 - 1.26)	2005	Modelled	IHME
1.13 (1.03 - 1.23)	2004	Modelled	IHME
1.13 (1.03 - 1.23)	2003	Modelled	IHME
1.12 (1.02 - 1.22)	2002	Modelled	IHME
1.1 (1.01 - 1.20)	2001	Modelled	IHME
1.08 (0.99 - 1.18)	2000	Modelled	IHME
1.06 (0.97 - 1.15)	1999	Modelled	IHME
1.03 (0.95 - 1.12)	1998	Modelled	IHME
1.01 (0.93 - 1.10)	1997	Modelled	IHME
1 (0.91 - 1.08)	1996	Modelled	IHME
0.99 (0.90 - 1.07)	1995	Modelled	IHME
0.97 (0.89 - 1.06)	1994	Modelled	IHME
0.97 (0.88 - 1.06)	1993	Modelled	IHME
0.96 (0.86 - 1.05)	1992	Modelled	IHME
0.97 (0.87 - 1.06)	1991	Modelled	IHME
0.99 (0.88 - 1.10)	1990	Modelled	IHME
0.5	2014	Survey/reported	US CDC
0.45	2016	Survey/reported	US CDC
0.46	2017	Survey/reported	US CDC
0.52	2010	Survey/reported	US CDC
0.51	2011	Survey/reported	US CDC
0.51	2012	Survey/reported	US CDC
0.53	2013	Survey/reported	US CDC
0.46	2015	Survey/reported	US CDC
0.42	2019	Survey/reported	US CDC: Viral Hepatitis Surveillance Report 2019 - Hepatitis B

Showing out of

Technical notes

HBV-related deaths

National

Download

Value	Year	Type	Source
4,486 (3,874 - 5,178)	2019	Modelled	IHME
4,422 (3,862 - 5,064)	2018	Modelled	IHME
4,345 (3,813 - 4,935)	2017	Modelled	IHME
4,516 (4,023 - 5,073)	2016	Modelled	IHME
4,584 (4,107 - 5,100)	2015	Modelled	IHME
4,423 (3,984 - 4,917)	2014	Modelled	IHME
4,261 (3,856 - 4,728)	2013	Modelled	IHME
4,108 (3,718 - 4,543)	2012	Modelled	IHME
3,965 (3,595 - 4,371)	2011	Modelled	IHME
3,817 (3,459 - 4,201)	2010	Modelled	IHME
3,739 (3,397 - 4,099)	2009	Modelled	IHME
3,654 (3,327 - 4,001)	2008	Modelled	IHME
3,569 (3,252 - 3,893)	2007	Modelled	IHME
3,498 (3,202 - 3,815)	2006	Modelled	IHME
3,408 (3,118 - 3,714)	2005	Modelled	IHME
3,292 (3,017 - 3,587)	2004	Modelled	IHME
3,262 (2,985 - 3,558)	2003	Modelled	IHME
3,196 (2,930 - 3,479)	2002	Modelled	IHME
3,120 (2,858 - 3,393)	2001	Modelled	IHME
3,041 (2,791 - 3,302)	2000	Modelled	IHME
2,947 (2,705 - 3,193)	1999	Modelled	IHME
2,845 (2,611 - 3,087)	1998	Modelled	IHME
2,752 (2,520 - 2,989)	1997	Modelled	IHME
2,688 (2,461 - 2,917)	1996	Modelled	IHME
2,639 (2,413 - 2,869)	1995	Modelled	IHME
2,576 (2,351 - 2,803)	1994	Modelled	IHME
2,533 (2,299 - 2,770)	1993	Modelled	IHME
2,479 (2,241 - 2,724)	1992	Modelled	IHME
2,475 (2,228 - 2,727)	1991	Modelled	IHME
2,498 (2,240 - 2,778)	1990	Modelled	IHME
11,522	2016	Modelled	WHO
1,662	2019	Survey/reported	US CDC: Viral Hepatitis Surveillance Report 2019 - Hepatitis B

Showing out of

Technical notes

Percent of liver cancer deaths attributable to HBV

National

Download

Value (%)	Year	Type	Source
12 (10 - 14)	2019	Modelled	IHME
12 (10 - 14)	2018	Modelled	IHME
12 (10 - 14)	2017	Modelled	IHME
12 (10 - 14)	2016	Modelled	IHME
12 (10 - 14)	2015	Modelled	IHME
12 (11 - 14)	2014	Modelled	IHME
12 (11 - 14)	2013	Modelled	IHME
12 (11 - 14)	2012	Modelled	IHME
12 (11 - 14)	2011	Modelled	IHME
12 (11 - 14)	2010	Modelled	IHME
13 (11 - 14)	2009	Modelled	IHME
13 (11 - 14)	2008	Modelled	IHME
13 (11 - 14)	2007	Modelled	IHME
13 (11 - 15)	2006	Modelled	IHME
13 (11 - 15)	2005	Modelled	IHME
13 (12 - 15)	2004	Modelled	IHME
13 (12 - 15)	2003	Modelled	IHME
13 (12 - 15)	2002	Modelled	IHME
13 (12 - 15)	2001	Modelled	IHME
13 (12 - 15)	2000	Modelled	IHME
13 (12 - 14)	1999	Modelled	IHME
13 (11 - 14)	1998	Modelled	IHME
13 (11 - 14)	1997	Modelled	IHME
13 (11 - 14)	1996	Modelled	IHME
13 (11 - 14)	1995	Modelled	IHME
13 (11 - 14)	1994	Modelled	IHME
13 (11 - 14)	1993	Modelled	IHME
13 (11 - 15)	1992	Modelled	IHME
13 (11 - 15)	1991	Modelled	IHME
13 (11 - 15)	1990	Modelled	IHME

Showing out of

Technical notes

Coverage of HepB birth dose

National

Download

Value (%)	Year	Type	Source
76	2017	Survey/reported	Hill HA et al

Newborns

Download

Value (%)	Year	Type	Source
67	2019	Survey/reported	WHO/UNICEF
66	2018	Survey/reported	WHO/UNICEF
64	2017	Survey/reported	WHO/UNICEF
64	2016	Survey/reported	WHO/UNICEF
72	2015	Survey/reported	WHO/UNICEF
72	2014	Survey/reported	WHO/UNICEF
74	2013	Survey/reported	WHO/UNICEF
72	2012	Survey/reported	WHO/UNICEF
69	2011	Survey/reported	WHO/UNICEF
64	2010	Survey/reported	WHO/UNICEF
61	2009	Survey/reported	WHO/UNICEF
55	2008	Survey/reported	WHO/UNICEF
53	2007	Survey/reported	WHO/UNICEF
50	2006	Survey/reported	WHO/UNICEF
50	2005	Survey/reported	WHO/UNICEF
48	2004	Survey/reported	WHO/UNICEF
39	2003	Survey/reported	WHO/UNICEF
21	2002	Survey/reported	WHO/UNICEF
69	2020	Survey/reported	WHO/UNICEF

Showing out of

Technical notes

Coverage of 3-dose hepatitis B vaccine

National

Download

Value (%)	Year	Type	Source
91	2017	Survey/reported	Hill HA et al

Infants

Download

Value (%)	Year	Type	Source
91	2019	Survey/reported	WHO/UNICEF
91	2020	Survey/reported	WHO/UNICEF

Showing out of

Technical notes

Proportion of persons living with HBV diagnosed

National

Download

Value (%)	Year	Type	Source
32	2016	Survey/reported	U.S. Department of Health and Human Services

Proportion of diagnosed HBV persons receiving appropriate treatment

National

Download

Value (%)	Year	Type	Source
18	2016	Survey/reported	Harris AM et al

Number of needles/syringes per PWID per year

People who inject drugs (PWID)

Download

Value	Year	Type	Source
30 (11 - 49)	2016	Survey/reported	NASEN, 2015; Wejnert C et al, 2016; Des Jarlais D et al , 2013

Technical notes

HBV National Action Plan

Source:

HBV elimination goal

Source:

Year of HBV elimination goal

2030

Source:

National prevalence survey within the last 5 years

Adopted

Division of Viral Hepatitis, National Center for HIV/AIDS, Viral Hepatitis, STD…

Estimates of economic burden

Adopted

Toy M et al

System for monitoring testing and treatment

Partially Adopted

Harris, A.M. et al

HepB birth dose policy

Yes

Source: WHO

Year of birth dose introduction

1999

Source: WHO

Recommendations for HBV testing of pregnant women

Adopted

U.S. Department of Health and Human Services

Eligible for HBV generic medicines

Source: MPP

Licensed point-of-care PCR testing to detect HBV

Not Adopted

HBV testing policy

Pregnant women, Risk-based

Source:

HBV testing recommendations for key population (i.e. migrants, foreign-born, etc)

Adopted

US CDC

No patient co-pays for HBsAg testing

Adopted

U.S Department of Health and Human Service

National treatment guidelines exist

Adopted

Terrault, N. A et al

Simplified care: No treatment co-pays

Partially Adopted

Adult HBV vaccination policy for high-risk populations

Adopted

Schillie, S et al

Public budget line for testing and treatment

Adopted

US CDC

HCV National Action Plan

Source:

HCV elimination goal

Source:

Year of HCV elimination goal

2030

Source:

National prevalence survey within the last 5 years

Adopted

Division of Viral Hepatitis, National Center for HIV/AIDS, Viral Hepatitis, STD…

Estimates of economic burden

Adopted

Roebuck MC, Liberman JN

System for monitoring testing and treatment

Partially Adopted

Isenhour C et al

Recommendations for HCV testing of pregnant women

Adopted

US CDC

Registration of originator HCV DAAs

Adopted

US Food and Drug Administration

Eligible for HCV generic medicines

Source: MPP

Licensed point-of-care PCR testing to detect HCV

Not Adopted

HCV testing policy

Universal

Source:

No patient co-pays for anti-HCV testing

Adopted

U.S Department of Health and Human Service

National treatment guidelines exist

Adopted

AASLD-IDSA

Simplified care: Non-specialists can prescribe treatment

Partially Adopted

Center for Health Law and Policy Innovation, Harvard Law School

Simplified care: No treatment co-pays

Partially Adopted

No fibrosis restrictions

Partially Adopted

Center for Health Law and Policy Innovation, Harvard Law School

No sobriety restrictions

Partially Adopted

Center for Health Law and Policy Innovation, Harvard Law School

National policy for harm reduction for persons who inject drugs

Adopted

Georgetown HIV Policy Lab

National policy for syringe exchange in federal prisons

Not Adopted

Georgetown HIV Policy Lab

At least one needle-syringe exchange program (NSP) operational

Yes

Source: Harm Reduction International

At least one opioid substitution therapy (OST) program operational

Yes

Source: Harm Reduction International

OST in at least one prison

Yes

Source: Harm Reduction International

% of substance use disorder facilities offering hepatitis testing

Many (31-60%)

Source: WHO

Decriminalization of possession of syringes and paraphernalia

Partially Adopted

Public budget line for testing and treatment

Adopted

US CDC

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National

Download

Value (%)	Year	Type	Source
1.18 (0.95 - 1.45)	2019	Modelled	IHME
1.18 (0.96 - 1.45)	2018	Modelled	IHME
1.18 (0.96 - 1.45)	2017	Modelled	IHME
1.15 (0.94 - 1.41)	2016	Modelled	IHME
1.12 (0.91 - 1.38)	2015	Modelled	IHME
1.12 (0.91 - 1.37)	2014	Modelled	IHME
1.11 (0.90 - 1.36)	2013	Modelled	IHME
1.1 (0.90 - 1.36)	2012	Modelled	IHME
1.1 (0.89 - 1.36)	2011	Modelled	IHME
1.1 (0.89 - 1.36)	2010	Modelled	IHME
1.11 (0.90 - 1.37)	2009	Modelled	IHME
1.12 (0.90 - 1.38)	2008	Modelled	IHME
1.13 (0.91 - 1.40)	2007	Modelled	IHME
1.14 (0.92 - 1.41)	2006	Modelled	IHME
1.14 (0.92 - 1.42)	2005	Modelled	IHME
1.14 (0.92 - 1.42)	2004	Modelled	IHME
1.14 (0.92 - 1.41)	2003	Modelled	IHME
1.14 (0.92 - 1.41)	2002	Modelled	IHME
1.14 (0.92 - 1.41)	2001	Modelled	IHME
1.14 (0.92 - 1.41)	2000	Modelled	IHME
1.13 (0.91 - 1.40)	1999	Modelled	IHME
1.11 (0.89 - 1.38)	1998	Modelled	IHME
1.08 (0.87 - 1.34)	1997	Modelled	IHME
1.06 (0.85 - 1.31)	1996	Modelled	IHME
1.04 (0.83 - 1.29)	1995	Modelled	IHME
1.02 (0.82 - 1.27)	1994	Modelled	IHME
1.01 (0.81 - 1.26)	1993	Modelled	IHME
1 (0.81 - 1.25)	1992	Modelled	IHME
0.99 (0.80 - 1.24)	1991	Modelled	IHME
0.99 (0.79 - 1.23)	1990	Modelled	IHME
1 (0.80 - 1.10)	2016	Survey/reported	Hofmeister MG et al, 2019 (Adjusted)
1 (0.80 - 1.20)	2010	Survey/reported	Denniston MM et al, 2014 (Unadjusted)
1.3 (1 - 1.50)	2002	Survey/reported	Armstrong GL wt al, 2006 (Unadjusted)
0.9 (0.70 - 1.20)	2015	Modelled	Blach et al, 2017
0.84 (0.75 - 0.96)	2016	Survey/reported	Rosenberg et al, 2018 (Unadjusted)
0.93	2016	Survey/reported	Rosenberg et al, 2018 (Adjusted)
1 (0.90 - 1.80)	2014	Modelled	Gower et al, 2014

Showing out of

Women of childbearing age (15–49 years)

Download

Value (%)	Year	Type	Source
0.49 (0.37 - 0.64)	2019	Modelled	Dugan et al., 2021

Technical notes

Prevalence of anti-HCV

National

Download

Value (%)	Year	Type	Source
1.7 (1.40 - 2)	2016	Survey/reported	Hofmeister MG et al, 2019 (Adjusted)
1.3 (1.20 - 1.50)	2010	Survey/reported	Denniston MM et al, 2014 (Unadjusted)
1.6 (1.30 - 1.90)	2002	Survey/reported	Armstrong GL wt al, 2006 (Unadjusted)
1.8 (1.50 - 2.30)	1994	Survey/reported	Alter MJ et al, 1999 (Unadjusted)
1.9 (1.50 - 2.50)	2002	Survey/reported	Ditah et al, 2014
1.3 (0.90 - 1.80)	2006	Survey/reported	Ditah et al, 2014
1.48	2019	Modelled	Jin et al. 2017
1.3 (1.20 - 2.40)	2014	Modelled	Gower et al, 2014

Showing out of

Men who have sex with men (MSM) Living with HIV

Download

Value (%)	Year	Type	Source
9.7 (7.10 - 12.60)	2019	Modelled	Jin et al. 2017

People who inject drugs (PWID)

Download

Value (%)	Year	Type	Source
53.1 (38.10 - 68)	2016	Modelled	Degenhardt L et al, 2017

Men who have sex with men (MSM)

Download

Value (%)	Year	Type	Source
4.4	2019	Modelled	Jin et al. 2017

Technical notes

Number of people living with chronic HCV (RNA+/cAg)

National

Download

Value	Year	Type	Source
2,502,880 (2,004,160 - 3,130,610)	1990	Modelled	IHME
2,546,430 (2,043,900 - 3,182,130)	1991	Modelled	IHME
2,596,220 (2,088,110 - 3,238,600)	1992	Modelled	IHME
2,650,820 (2,132,340 - 3,306,200)	1993	Modelled	IHME
2,709,170 (2,180,460 - 3,372,500)	1994	Modelled	IHME
2,770,670 (2,230,810 - 3,444,260)	1995	Modelled	IHME
2,848,100 (2,293,540 - 3,535,790)	1996	Modelled	IHME
2,945,160 (2,370,670 - 3,660,720)	1997	Modelled	IHME
3,046,070 (2,451,420 - 3,794,290)	1998	Modelled	IHME
3,134,450 (2,518,830 - 3,904,060)	1999	Modelled	IHME
3,193,420 (2,568,350 - 3,968,570)	2000	Modelled	IHME
3,230,980 (2,602,030 - 4,000,380)	2001	Modelled	IHME
3,267,410 (2,634,270 - 4,038,940)	2002	Modelled	IHME
3,303,160 (2,665,360 - 4,086,760)	2003	Modelled	IHME
3,338,110 (2,695,040 - 4,137,130)	2004	Modelled	IHME
3,372,040 (2,724,350 - 4,187,150)	2005	Modelled	IHME
3,392,560 (2,742,490 - 4,212,400)	2006	Modelled	IHME
3,394,700 (2,747,430 - 4,209,860)	2007	Modelled	IHME
3,389,100 (2,745,630 - 4,198,660)	2008	Modelled	IHME
3,387,400 (2,747,660 - 4,185,320)	2009	Modelled	IHME
3,402,520 (2,765,160 - 4,193,890)	2010	Modelled	IHME
3,432,790 (2,786,310 - 4,230,320)	2011	Modelled	IHME
3,467,850 (2,815,500 - 4,270,910)	2012	Modelled	IHME
3,507,740 (2,849,370 - 4,315,400)	2013	Modelled	IHME
3,552,530 (2,888,320 - 4,365,520)	2014	Modelled	IHME
3,601,660 (2,913,580 - 4,419,880)	2015	Modelled	IHME
3,722,760 (3,022,960 - 4,564,600)	2016	Modelled	IHME
3,829,820 (3,111,390 - 4,697,660)	2017	Modelled	IHME
3,850,280 (3,123,950 - 4,718,760)	2018	Modelled	IHME
3,865,100 (3,131,620 - 4,746,640)	2019	Modelled	IHME
2,936,000 (2,231,000 - 3,826,000)	2015	Modelled	Blach et al, 2017
2,400,000	2016	Survey/reported	US CDC

Showing out of

Women of childbearing age (15–49 years)

Download

Value	Year	Type	Source
368,000 (280,000 - 480,000)	2019	Modelled	Dugan et al., 2021

Number of new cases of HCV

National

Download

Value	Year	Type	Source
57,500 (45,500 - 196,000)	2019	Survey/reported	US CDC: Viral Hepatitis Surveillance Report 2019 - Hepatitis C

Rate of new HCV cases

American Indian/Alaska Native

Download

Value (Number of new cases per 100,000 persons)	Year	Type	Source
3.6	2019	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2019
3.6	2018	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2018
2.9	2017	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2017
3.1	2016	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2016
1.7	2015	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2016
1.3	2014	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2014
1.7	2013	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2013
2	2012	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2012
1.08	2011	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2011
0.5	2010	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2010
0.46	2009	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2009
0.5	2008	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2008

Showing out of

Asian/Pacific Islander

Download

Value (Number of new cases per 100,000 persons)	Year	Type	Source
0.2	2019	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2019
0.2	2018	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2018
0.1	2017	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2017
0.1	2016	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2016
0.1	2015	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2016
0.1	2014	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2014
0.1	2013	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2013
0.1	2012	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2012
0.05	2011	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2011
0	2010	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2010
0.04	2009	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2009
0.04	2008	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2008

Showing out of

Black, non-Hispanic

Download

Value (Number of new cases per 100,000 persons)	Year	Type	Source
0.7	2019	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2019
0.6	2018	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2018
0.5	2017	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2017
0.3	2016	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2016
0.3	2015	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2016
0.2	2014	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2014
0.2	2013	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2013
0.2	2012	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2012
0.14	2011	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2011
0.12	2010	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2010
0.1	2009	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2009
0.2	2008	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2008

Showing out of

Hispanic

Download

Value (Number of new cases per 100,000 persons)	Year	Type	Source
0.6	2019	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2019
0.5	2018	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2018
0.4	2017	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2017
0.4	2016	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2016
0.3	2015	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2016
0.2	2014	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2014
0.2	2013	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2013
0.2	2012	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2012
0.17	2011	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2011
0.16	2010	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2010
0.1	2009	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2009
0.1	2008	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2008

Showing out of

White, non-Hispanic

Download

Value (Number of new cases per 100,000 persons)	Year	Type	Source
1.4	2019	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2019
1.3	2018	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2018
1.2	2017	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2017
1.1	2016	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2016
0.9	2015	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2016
0.8	2014	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2014
0.8	2013	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2013
0.6	2012	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2012
0.47	2011	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2011
0.32	2010	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2010
0.3	2009	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2009
0.3	2008	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2008

Showing out of

0-19 year olds

Download

Value (Number of new cases per 100,000 persons)	Year	Type	Source
0.1	2019	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2019
0.1	2018	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2018
0.1	2017	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2017
0.1	2016	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2016
0.1	2015	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2016
0.1	2014	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2014
0.1	2013	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2013
0.11	2012	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2012
0.1	2011	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2011
0	2010	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2010
0	2009	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2009

Showing out of

Less than 15 years old

Download

Value (Number of new cases per 100,000 persons)	Year	Type	Source
0	2008	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2008

20-29 year olds

Download

Value (Number of new cases per 100,000 persons)	Year	Type	Source
2.9	2019	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2019
3.1	2018	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2018
2.8	2017	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2017
2.7	2016	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2016
2.4	2015	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2016
2.2	2014	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2014
2	2013	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2013
1.73	2012	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2012
1.18	2011	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2011
0.8	2010	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2010
0.7	2009	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2009

Showing out of

25-39 year olds

Download

Value (Number of new cases per 100,000 persons)	Year	Type	Source
0.5	2008	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2008

30-39 year olds

Download

Value (Number of new cases per 100,000 persons)	Year	Type	Source
3.2	2019	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2019
2.6	2018	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2018
2.3	2017	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2017
2.2	2016	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2016
1.7	2015	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2016
1.7	2014	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2014
1.3	2013	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2013
1.1	2012	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2012
0.8	2011	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2011
0.6	2010	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2010
0.5	2009	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2009

Showing out of

15-24 year olds

Download

Value (Number of new cases per 100,000 persons)	Year	Type	Source
0.4	2008	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2008

50-59 year olds

Download

Value (Number of new cases per 100,000 persons)	Year	Type	Source
1.1	2019	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2019
0.9	2018	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2018
0.8	2017	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2017
0.6	2016	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2016
0.6	2015	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2016
0.4	2014	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2014
0.5	2013	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2013
0.4	2012	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2012
0.3	2011	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2011
0.3	2010	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2010
0.3	2009	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2009

Showing out of

40-49 year olds

Download

Value (Number of new cases per 100,000 persons)	Year	Type	Source
1.7	2019	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2019
1.3	2018	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2018
1.1	2017	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2017
1.2	2016	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2016
0.9	2015	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2016
0.7	2014	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2014
0.7	2013	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2013
0.6	2012	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2012
0.5	2011	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2011
0.4	2010	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2010
0.5	2009	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2009

Showing out of

Over 40 years old

Download

Value (Number of new cases per 100,000 persons)	Year	Type	Source
0.3	2008	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2008

Over 60 years old

Download

Value (Number of new cases per 100,000 persons)	Year	Type	Source
0.5	2019	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2019
0.4	2018	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2018
0.3	2017	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2017
0.2	2016	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2016
0.1	2015	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2016
0.1	2014	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2014
0.1	2013	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2013
0.1	2012	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2012
0.07	2011	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2011
0	2010	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2010
0.04	2009	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2009

Showing out of

Technical notes

HCV-related death rate

National

Download

Value (Deaths per 100,000)	Year	Type	Source
11.9 (10.80 - 13.10)	2019	Modelled	IHME
11.8 (10.70 - 13.10)	2018	Modelled	IHME
11.7 (10.60 - 12.90)	2017	Modelled	IHME
11.73 (10.80 - 12.80)	2016	Modelled	IHME
11.4 (10.60 - 12.40)	2015	Modelled	IHME
11.1 (10.30 - 12.10)	2014	Modelled	IHME
10.9 (10.10 - 11.80)	2013	Modelled	IHME
10.7 (9.88 - 11.50)	2012	Modelled	IHME
10.4 (9.69 - 11.20)	2011	Modelled	IHME
10.1 (9.40 - 10.90)	2010	Modelled	IHME
9.99 (9.28 - 10.80)	2009	Modelled	IHME
9.77 (9.09 - 10.50)	2008	Modelled	IHME
9.54 (8.88 - 10.30)	2007	Modelled	IHME
9.4 (8.76 - 10.10)	2006	Modelled	IHME
9.24 (8.62 - 9.95)	2005	Modelled	IHME
9.01 (8.41 - 9.68)	2004	Modelled	IHME
9 (8.41 - 9.66)	2003	Modelled	IHME
8.84 (8.27 - 9.48)	2002	Modelled	IHME
8.62 (8.08 - 9.25)	2001	Modelled	IHME
8.4 (7.87 - 9.01)	2000	Modelled	IHME
8.17 (7.63 - 8.78)	1999	Modelled	IHME
7.94 (7.39 - 8.53)	1998	Modelled	IHME
7.75 (7.23 - 8.33)	1997	Modelled	IHME
7.63 (7.10 - 8.20)	1996	Modelled	IHME
7.56 (7.03 - 8.13)	1995	Modelled	IHME
7.4 (6.87 - 7.95)	1994	Modelled	IHME
7.23 (6.70 - 7.80)	1993	Modelled	IHME
6.95 (6.41 - 7.53)	1992	Modelled	IHME
6.8 (6.24 - 7.43)	1991	Modelled	IHME
6.68 (6.07 - 7.37)	1990	Modelled	IHME
4.45	2016	Survey/reported	US CDC, 2016
4.91	2015	Survey/reported	US CDC, 2020
5.01	2014	Survey/reported	US CDC, 2019
5.03	2013	Survey/reported	US CDC, 2018
4.96	2012	Survey/reported	US CDC, 2017
3.33	2019	Survey/reported	US CDC: Viral Hepatitis Surveillance Report 2019 - Hepatitis C

Showing out of

Technical notes

HCV-related deaths

National

Download

Value	Year	Type	Source
39,158 (35,520 - 43,124)	2019	Modelled	IHME
38,668 (35,028 - 42,654)	2018	Modelled	IHME
38,054 (34,421 - 41,900)	2017	Modelled	IHME
37,842 (34,759 - 41,187)	2016	Modelled	IHME
36,565 (33,841 - 39,660)	2015	Modelled	IHME
35,460 (32,872 - 38,434)	2014	Modelled	IHME
34,425 (31,893 - 37,241)	2013	Modelled	IHME
33,475 (31,022 - 36,115)	2012	Modelled	IHME
32,530 (30,185 - 35,022)	2011	Modelled	IHME
31,333 (29,056 - 33,738)	2010	Modelled	IHME
30,611 (28,418 - 33,016)	2009	Modelled	IHME
29,671 (27,590 - 31,990)	2008	Modelled	IHME
28,701 (26,694 - 30,881)	2007	Modelled	IHME
27,985 (26,076 - 30,138)	2006	Modelled	IHME
27,242 (25,403 - 29,330)	2005	Modelled	IHME
26,287 (24,541 - 28,240)	2004	Modelled	IHME
26,004 (24,309 - 27,918)	2003	Modelled	IHME
25,293 (23,674 - 27,122)	2002	Modelled	IHME
24,439 (22,913 - 26,212)	2001	Modelled	IHME
23,578 (22,096 - 25,300)	2000	Modelled	IHME
22,700 (21,193 - 24,409)	1999	Modelled	IHME
21,850 (20,334 - 23,461)	1998	Modelled	IHME
21,121 (19,696 - 22,687)	1997	Modelled	IHME
20,584 (19,155 - 22,118)	1996	Modelled	IHME
20,201 (18,781 - 21,711)	1995	Modelled	IHME
19,577 (18,175 - 21,045)	1994	Modelled	IHME
18,940 (17,555 - 20,435)	1993	Modelled	IHME
18,010 (16,624 - 19,510)	1992	Modelled	IHME
17,433 (16,011 - 19,047)	1991	Modelled	IHME
16,950 (15,387 - 18,693)	1990	Modelled	IHME
21,698	2016	Modelled	WHO
14,242	2019	Survey/reported	US CDC: Viral Hepatitis Surveillance Report 2019 - Hepatitis C

Showing out of

Technical notes

Percent of liver cancer deaths attributable to HCV

National

Download

Value (%)	Year	Type	Source
39 (35 - 43)	2019	Modelled	IHME
39 (35 - 43)	2018	Modelled	IHME
39 (35 - 43)	2017	Modelled	IHME
40 (36 - 44)	2016	Modelled	IHME
41 (37 - 44)	2015	Modelled	IHME
41 (37 - 44)	2014	Modelled	IHME
41 (37 - 44)	2013	Modelled	IHME
41 (37 - 44)	2012	Modelled	IHME
40 (37 - 44)	2011	Modelled	IHME
40 (37 - 44)	2010	Modelled	IHME
40 (37 - 43)	2009	Modelled	IHME
40 (37 - 43)	2008	Modelled	IHME
40 (37 - 43)	2007	Modelled	IHME
40 (37 - 42)	2006	Modelled	IHME
39 (36 - 42)	2005	Modelled	IHME
39 (36 - 42)	2004	Modelled	IHME
39 (36 - 42)	2003	Modelled	IHME
39 (36 - 42)	2002	Modelled	IHME
39 (36 - 42)	2001	Modelled	IHME
39 (36 - 42)	2000	Modelled	IHME
39 (36 - 42)	1999	Modelled	IHME
39 (36 - 42)	1998	Modelled	IHME
39 (36 - 42)	1997	Modelled	IHME
39 (36 - 42)	1996	Modelled	IHME
39 (35 - 42)	1995	Modelled	IHME
38 (35 - 42)	1994	Modelled	IHME
38 (35 - 42)	1993	Modelled	IHME
38 (35 - 41)	1992	Modelled	IHME
38 (35 - 41)	1991	Modelled	IHME
38 (34 - 41)	1990	Modelled	IHME

Showing out of

Technical notes

Number of persons initiating HCV treatment

National

Download

Value	Year	Type	Source
109,096	2014	Survey/reported	Teshale et al
164,232	2015	Survey/reported	Teshale et al
134,285	2016	Survey/reported	Teshale et al
114,419	2017	Survey/reported	Teshale et al
122,664	2018	Survey/reported	Teshale et al
114,893	2019	Survey/reported	Teshale et al
83,740	2020	Survey/reported	Teshale et al

Showing out of

Demographic breakdown of persons treated for HCV

Females (2014-2020)

Download

Value (%)	Year	Type	Source
39.2	2020	Survey/reported	Teshale et al

Males (2014-2020)

Download

Value (%)	Year	Type	Source
59.6	2020	Survey/reported	Teshale et al

Persons born after 1965

Download

Value (%)	Year	Type	Source
17.4	2014	Survey/reported	Teshale et al
51.3	2020	Survey/reported	Teshale et al

Showing out of

Persons born during 1945–1965

Download

Value (%)	Year	Type	Source
73.6	2014	Survey/reported	Teshale et al
46.3	2020	Survey/reported	Teshale et al

Showing out of

Number of needles/syringes per PWID per year

People who inject drugs (PWID)

Download

Value	Year	Type	Source
30 (11 - 49)	2016	Survey/reported	NASEN, 2015; Wejnert C et al, 2016; Des Jarlais D et al , 2013

Technical notes

Proportion of persons living with HCV diagnosed

National

Download

Value (%)	Year	Type	Source
60	2016	Survey/reported	U.S. Department of Health and Human Services

Proportion of persons living with HCV who have cleared HCV infection

National

Download

Value (%)	Year	Type	Source
43	2016	Survey/reported	U.S. Department of Health and Human Services

HBV National Action Plan

Source:

HBV elimination goal

Source:

Year of HBV elimination goal

2030

Source:

National prevalence survey within the last 5 years

Adopted

Division of Viral Hepatitis, National Center for HIV/AIDS, Viral Hepatitis, STD…

Estimates of economic burden

Adopted

Toy M et al

System for monitoring testing and treatment

Partially Adopted

Harris, A.M. et al

HepB birth dose policy

Yes

Source: WHO

Year of birth dose introduction

1999

Source: WHO

Recommendations for HBV testing of pregnant women

Adopted

U.S. Department of Health and Human Services

Eligible for HBV generic medicines

Source: MPP

Licensed point-of-care PCR testing to detect HBV

Not Adopted

HBV testing policy

Pregnant women, Risk-based

Source:

HBV testing recommendations for key population (i.e. migrants, foreign-born, etc)

Adopted

US CDC

No patient co-pays for HBsAg testing

Adopted

U.S Department of Health and Human Service

National treatment guidelines exist

Adopted

Terrault, N. A et al

Simplified care: No treatment co-pays

Partially Adopted

Adult HBV vaccination policy for high-risk populations

Adopted

Schillie, S et al

Public budget line for testing and treatment

Adopted

US CDC

HCV National Action Plan

Source:

HCV elimination goal

Source:

Year of HCV elimination goal

2030

Source:

National prevalence survey within the last 5 years

Adopted

Division of Viral Hepatitis, National Center for HIV/AIDS, Viral Hepatitis, STD…

Estimates of economic burden

Adopted

Roebuck MC, Liberman JN

System for monitoring testing and treatment

Partially Adopted

Isenhour C et al

Recommendations for HCV testing of pregnant women

Adopted

US CDC

Registration of originator HCV DAAs

Adopted

US Food and Drug Administration

Eligible for HCV generic medicines

Source: MPP

Licensed point-of-care PCR testing to detect HCV

Not Adopted

HCV testing policy

Universal

Source:

No patient co-pays for anti-HCV testing

Adopted

U.S Department of Health and Human Service

National treatment guidelines exist

Adopted

AASLD-IDSA

Simplified care: Non-specialists can prescribe treatment

Partially Adopted

Center for Health Law and Policy Innovation, Harvard Law School

Simplified care: No treatment co-pays

Partially Adopted

No fibrosis restrictions

Partially Adopted

Center for Health Law and Policy Innovation, Harvard Law School

No sobriety restrictions

Partially Adopted

Center for Health Law and Policy Innovation, Harvard Law School

National policy for harm reduction for persons who inject drugs

Adopted

Georgetown HIV Policy Lab

National policy for syringe exchange in federal prisons

Not Adopted

Georgetown HIV Policy Lab

At least one needle-syringe exchange program (NSP) operational

Yes

Source: Harm Reduction International

At least one opioid substitution therapy (OST) program operational

Yes

Source: Harm Reduction International

OST in at least one prison

Yes

Source: Harm Reduction International

% of substance use disorder facilities offering hepatitis testing

Many (31-60%)

Source: WHO

Decriminalization of possession of syringes and paraphernalia

Partially Adopted

Public budget line for testing and treatment

Adopted

US CDC

Overview

HBV elimination goal

Year of goal

2030

HCV elimination goal

Year of goal

2030

Prevalence (national)

Modelled

Survey/surveillance

Roberts H et al, 2016

HCV (anti-HCV)

HCV

53.10 (%)

2016, latest modelled

(38.10 - 68(%))

Degenhardt L et al, 2017

Birth dose vaccination coverage (national)

Survey/surveillance

No. of syringes/PWID/year

Survey/surveillance

HCV

2016

(11 - 49)

NASEN, 2015; Wejnert C et al, 2016; Des Jarlais D et al , 2013

Eligible for HBV generic medicines

Eligible for HCV generic medicines

Download National Hepatitis Elimination Profile (N-HEP)

Latest news

Clusters of Children with Severe Acute Hepatitis Reported Globally: Is Adenovirus F- 41 the Cause?

25 Apr 2022

View all

Action plan

A Comprehensive Immunization Strategy to Eliminate Transmission of Hepatitis B Virus Infection in the United States Recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: Immunization of Adults

2006

Mast, E. E.,Weinbaum, C. M.,Fiore, A. E.,Alter, M. J.,Bell, B. P.,Finelli, L.,Rodewald, L. E.,Douglas, J. M., Jr.,Janssen, R. S.,Ward, J. W., Advisory Committee on Immunization Practices, Centers for Disease Control and Prevention

View all

Elimination champion

Dr. Angela Park (2021)

We want to get to the root causes of problems that are identified...It's about how you can innovate without changing an entire system... For example, you're just changing the way you're offering testing. It doesn't cost money. It's not a big invention, it's not technological. But you can change something and have a big impact just by finding out what the root cause of a problem is.

Rachel Gonzalez (2021)

It is revolutionary what the Hepatitis C Innovation Team (HIT) did because you're talking about a federal health care system made up of more than 150 medical centers and 1000 sites of care. How do you move this giant ship? We built a community and said these goals really are aspirational, but we believe in the field teams. We believe in their ability to be creative -- to push innovation. . . If you [only] work in [a] safe space, you’ll never find many of the genuine breakthroughs that came out of HIT.